| INTRODUCTION
Enterobacteriaceae are the most common pathogens causing community-and hospital-acquired infections 1 and the antibiotic resistance Enterobacteriaceae have been reported worldwide. The infection tends to exert hospital burden for both health care institution and patient. 2 The major driving force of antibiotic resistance within this family is the production of broad spectrum β-lactamases including extended spectrum β-lactamases (ESBLs), plasmid mediated AmpC cephalosporinases (pAmpC), and carbapenemases. Furthermore, extended spectrum cephalosporin resistance (ESC-R) Enterobacteriaceae phenotype may harbor one or many types of broad spectrum β-lactamases and may also harbor multiple β-lactamase genes of the same classes of β-lactamases in one organism. 3 Because of these β-lactamase genes are mediated on plasmid, the resistance genes were easily transferred to other bacterial cells, species, and genus. These results inferred to the increasing rates of ESC-R Enterobacteriaceae.
Plasmid-mediated AmpC β-lactamase genes are descended from the chromosomal ampC genes of several organisms such as Citrobacter fruendii, Enterobacter cloacae, Hafnia alvei, and Morganella morganii. 4 Because of lack association with regulation genes (ampR), pAmpC is usually overexpression. 5 Although less common than ESBLs, plasmid
AmpC β-lactamases (pAmpC) have been reported worldwide with various prevalence rates. These enzymes confer resistance to penicillins, first to third generation cephalosporins, cephamycins, monobactams, and also poorly inhibited by the commercially available β-lactamase inhibitors such as clavulanic acid. Up to date, at least eight classes of pAmpC have been characterized. 4, 6 The name of pAmpC β-lactamases were nominated randomly without typical of β-lactamases nomenclature, relying on resistance produced to cefoxitin (FOX), cephamy- To cope with the increasing diversity of pAmpC, molecular detection of pAmpC typing must be developed for further epidemiological survey. The aim of this study was to develop a multiplex PCR (mPCR) for rapid identification and molecular typing of pAmpC for further investigation of the prevalence and molecular epidemiology of pAmpC in cefoxitin resistant (FOX-R) Enterobacteriaceae isolates.
| MATERIALS AND METHODS

| Bacterial isolates
A total of 30 non-duplicated Enterobacteriaceae isolates which phenotypically presented with different characteristics of susceptibility to cefoxitin (FOX), third generation cephalosporin (3rd Ceph), and carbapenem were utilized in specificity testing of developed method ( 
| DNA extraction
The simple boiling method was applied to extract the DNA from Enterobacteriaceae isolates. Three to five overnight bacterial colonies on MacConkey agar were suspended in sterile distilled water to a turbidity of 0.5 McFarland and the bacterial cell suspension was heated at 95°C in 10 minutes. After centrifugation, the supernatant of each sample was used as DNA template without further purification.
| Designed primers
All pAmpC sequences recorded at Lahey Clinic website (http://www. CDeg2 (5′-GCCAAAICCRYYRGTSGAGCC-3′) primers 12 were utilized to detect several genes encoding pAmpC β-lactamases. The forward CDeg1 primer was utilized in combination with ECB and FOX reverse primers for amplification of ECB and FOX genes while the CIT and MOX forward primers were designed and used with the CDeg2 reverse primer for amplification of CIT and MOX genes. Furthermore, the primer sets for DHA and ACC genes were also designed ( Table 2 ). 
| Optimized PCR condition
| Validation of mPCR
The sensitivity of mPCR assay was reported via the limit of detection (LOD). Suspension of known carrying pAmpC strains were The specificity of our developed method was verified via 30 clinical isolates of various susceptibility patterns (Table 1) Briefly, the partial ECB genes were amplified by PCR using CDeg1 and CDeg2 primers ( Table 2 ). The PCR products (800 bp) were purified and then sent for sequencing.
| RESULTS
Our mPCR for pAmpC typing was successfully developed and optimized. The sensitivity of the mPCR was determined with the known DNA templates at different concentrations and the limit of detection (LOD) within 35 cycles was defined at 1.25 ηg/μL of DNA template (2.5 ηg per reaction) (Figure 1 genes via our system ( Figure 2 and Table 3 ). The sequencing data of these three isolates were confirmed that all three ECB sequences belonged to ACT type, which were possibly identified only by our developed method.
| DISCUSSION
An increasing diversification of pAmpC genes has been reported in Enterobacteriaceae worldwide. 4, 6 Differentiation of pAmpC β-lactamase producing isolates from other broad spectrum β-lactamase expressing Enterobacteriaceae is essential to address surveillance and epidemiology as well as hospital infection control issued associated with transferable resistance mechanisms. Unlike ESBLs, AmpC enzymes are not inhibited by β-lactamase inhibitors (clavulanic acid, sulbactam, and tazobactam), except for avibactam. 13 Since AmpC enzymes are encoded by both chromosome and plasmid, plasmid types are related to broad spectrum β-lactam resistance phenotype. It is the challenge to identify plasmid carrying AmpC isolates. Furthermore, the production of dual or multiple enzymes that showed different characteristics in one isolate may hinder detection by phenotypic method 13 Among seven AmpC producing isolates that showed negative by phenotypic method but positive by molecular methods, six isolates produced ESBLs and one isolates produced carbapenemase, respectively. In addition, phenylboronic acid method has good specificity (99%) but low sensitivity. 14 From these reasons referred that only 16 isolates were identified as AmpC producers by phenotypic The strategy of our method using same forward primers or reverse primers offers low price and convenient for our mPCR since all primers can be combined in one tube. Our developed method is sensitive and able to detect target genes at nano-gram level. Nevertheless, the DNA templates used in this study were a product from crude extraction, therefore the LOD of each gene should be much lower than the validated ones. Furthermore, our system showed both high sensitivity and specificity. All positive samples with ampC ID kit can be detected by our tested system and three more isolates can identify ACT/MIR β-lactamase. This results may result of our primer design cope with more variants of ACT/MIR -AmpC types while the ampC ID kit can amplify only ACT-1, -2, -8, -12 and MIR 1-3, 6-7 and -8. 16 Based on this result, it is indicated that most of Enterobacteriaceae isolated from Thailand possess new variant ACT/MIR genes. In addition to DHAtype β-lactamase that was highly prevalent in the Asia-Pacific region 9 cannot be detected by CDeg1 and CDeg2 primers, 12 CDeg and DHA primer sets are needed in plasmid mediated AmpC screening and our mPCR system is benefit for identification of AmpC plasmid types in clinical isolates.
In conclusion, we presented a new tool for pAmpC typing that has high discriminatory power for pAmpC classification and coped with all T A B L E 3 Plasmid mediated AmpC β-lactamase among 28 cefoxitin and third generation cephalosporin resistant Enterobacteriaceae isolates characterized by commercial ampC ID kit and developed mPCR method
